MacAndrews & Forbes has a strong commitment to philanthropy, with its core mission focused on women’s health issues, education, and the arts. Led by Ronald O. Perelman’s vision and dedication, the company established the Revlon/UCLA Women’s Cancer Research Program in 1994 for research into the causes and treatment of breast and ovarian cancer. The program is responsible for the development of Herceptin, the first genetically based treatment for a major cancer to be approved by the FDA.

The company also founded the Ronald O. Perelman Department of Dermatology at NYU Medical Center, recognized internationally as a leader in patient care, education and research for skin diseases. Over the years, MacAndrews & Forbes has also provided significant support for such organizations as the National Breast Cancer Coalition Fund, Carnegie Hall, the Solomon R. Guggenheim Museum, Memorial Sloan-Kettering Hospital and Mr. Perelman’s alma mater, The University of Pennsylvania.